← Back to news
S

Seeking Alpha: News

Burry sparks AI spending debate, defends record as critics question timing

B

Quant snapshot: Amerigo, Allianz lead strong buys as Ashford Hospitality, Hudson Pacific lag

B

Notable healthcare headlines for the week: J&J, Masimo and Bayer in focus

B

Investors shift from AI darlings to ‘heavy asset’ stocks in search of stability

B

Trump pressures Netflix over Susan Rice as Warner deal faces regulatory scrutiny

B

Earnings week ahead: NVDA, CRM, HD, BIDU, LOW, DELL, SNOW, AMC, ZM, and more

S

Trump's EPA rolls back rules on mercury emissions from power plants

B

Key deals this week: Visa, Hims & Hers Health, Salesforce and more

S

TXNM Energy wins FERC clearance for $11.5B Blackstone deal

S

Nvidia: Have investors become immune to good results from the AI bellwether?

S

NASA’s Artemis II rocket launch faces delay after technical issue

S

France says EU has tools to respond to Trump’s latest tariffs: FT

S

Amazon draws mixed signals as hedge funds place opposing bets

S

33 of 52 S&P 500 companies post EPS growth in latest earnings week: Earnings scorecard

B

Real estate stocks continue to advance

B

Half of the S&P 500 utilities companies beat earnings this week

B

Trump to hike global tariffs to 15% from 10%

B

CosMc's afterlife: McDonald's secret weapon to take on Starbucks and Dutch Bros

B

Blue Owl Capital gets reprieve after Saba Capital and Cox Capital’s tender offers

B

Retail rundown: Dollar Tree and Five Below could benefit from new tariff structure

S

4 out of 6 S&P 500 energy stocks beat EPS estimates this week: Earnings Scorecard

S

Insider trades: Microsoft, Walt Disney among notable names this week

S

Hedge funds make contrasting calls on Microsoft

S

Is Apple a potential Mag 7 haven if the AI capex boom becomes a bust?

S

Big banks, Coinbase among gainers; Blue Owl in losers: week's financials wrap

S

Microsoft names new gaming head as company veteran Phil Spencer retires

S

Teva, Medincell granted FDA review for long-acting antipsychotic

S

After the Supreme Court's tariff ruling, here's what could be next for stocks

B

OpenAI adjusts spending expectations: CNBC

S

Trending stocks as Wall Street ends higher despite cooling growth, Supreme Court tariff ruling

S

Amazon, ASML lead tech sector layoffs in 2026 as total crosses 26,000

S

Trump’s new 10% global tariff to take effect on Feb. 24

S

Vanda surges as FDA approves Bysanti for bipolar disorder, schizophrenia

B

Supreme Court tariff ruling seen curbing Trump's ability to use energy as a weapon

B

Berkshire's PacifiCorp to pay $575M settlement of U.S. government's wildfire claims

S

AMH outlines 2026 core FFO growth target of up to $1.95 per share while moderating development pace

S

Search Minerals settles $395K debt through shares-for-debt deals

S

Gold and silver settle higher, with uncertainty over next steps following Trump tariff ruling

S

Helix Energy Solutions Group Q4 2025 Earnings Preview

B

Summit Therapeutics Q4 2025 Earnings Preview

B

Diversified Healthcare Trust Q4 2025 Earnings Preview

B

BioMarin Pharmaceutical Q4 2025 Earnings Preview

B

Vir Biotechnology Q4 2025 Earnings Preview

B

Myriad Genetics Q4 2025 Earnings Preview

B

Ultra Clean Holdings Q4 2025 Earnings Preview

B

Infinico Metals shareholders approve 15-for-1 share consolidation

B

Trinity Biotech falls below Nasdaq public float requirement

B

ConocoPhillips weighs selling Permian assets worth $2B - Bloomberg

B

iPower GAAP EPS of -$1.08, revenue of $7.1M

S

FDA to review Savara resubmitted Molbreevi BLA

S